TUE Validities

When reviewing TUE applications, the Independent TUE Committee follow the guidelines published by WADA for TUE validities for common medical conditions as indicated in the table below.


Attention Deficit Hyperactivity Disorder (ADHD) in children and adults First application - up to 1 year. Second and subsequent applications - up to 4 years.
Adrenal insufficiency (Addison's Disease) Primary insufficiency - up to 10 years with annual review by an endocrinologist. Secondary insufficiency - 4 to 12 weeks, noting that a new TUE will only be issued after clinical and biological verification of a further need due to persisting adrenal insufficiency.
Anaphylaxis (retroactive application only) Up to the date of the last administration of the prohibited substance(s).
Androgen deficiency/ male hypogonadism 1 year.
Arterial hypertension 4 years (no annual review). Eligible for retroactive approval.
Asthma 4 years with annual review; new pulmonary function tests every 4 years.
Diabetes mellitus 10 years with annual review.
Female to Male (FtM) transsexuals 10 years with annual review including testosterone dosing regimens.
Growth hormone deficiency 4 years with annual review by an endrocrinologist, except for demonstrable genetic, congenital or hypothalamic-pituitary abnormality (in which case, 8 years).
Inflammatory bowel disease 4 years with annual review by a specialist.
Intrinsic sleep disorders 4 years with annual review by a sleep specialist.
Intravenous infusions Normally a single intervention of relatively short duration. Eligible for retroactive approval.
Musculoskeletal conditions Acute - 1 month, with renewals requiring a full review and diagnostic reassessment. Chronic inflammatory musculoskeletal - up to 1 year.
Neuropathic pain Acute - days or weeks. Chronic - 1 to 4 years with an annual review by a relevant specialist.
Polycystic ovarian syndrome/unexplained infertility Clomiphene citrate - 2 years. Spironolactone - 10 years with annual review by a specialist.
Post-infectious cough Normally no longer than 2 months.
Renal transplant 10 years with annual review by a renal specialist.
Sinusitis/rhinosinusitis Normally no longer than 2 months.